glp-1 manufacturing Disruptive Innovations Shaping the Landscape GLP‑1 Manufacturing Containment Solutions |
Description
Across major clinical trials (LEADER, REWIND, SUSTAIN, SURPASS), no increase in MTC incidence has been observed, and human C-cells express very low levels of GLP-1 receptors
This study aimed to determine whether the addition of liraglutide 1.8 mg (Victoza) to LAGB leads to clinically significant improvements in HbA1c compared to LAGB alone
GLP-1 receptors aren't just sitting in your gut regulating appetite
A multivariable analysis was conducted to predict the presence of retained gastric contents on EGD, with the primary predictor being GLP-1RA use
Ding WG, Gromada J
2021;911 doi: 10.1016/j.ejphar.2021.174482
